NewAmsterdam Pharma (NAMS)

NewAmsterdam Pharma (NAMS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• NAMS last traded at $19.56, -2.49% on the day.
• NewAmsterdam Pharma: P/E -9.0, revenue $7.12M over the last four quarters.
• Over the past year NAMS returned -49.48%; year to date -44.24%.

Updated 2026-11-03 00:43 UTC